WS
IMGN

Wedbush Securities’s Immunogen Inc IMGN Stock Holding History

Wedbush Securities’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-19,581
Closed -$53K – 1038
2019
Q1 		$53K Buy
+19,581
New +$84.8K 0.01% 890
2017
Q1 		– Sell
-24,109
Closed -$49K – 891
2016
Q4 		$49K Buy
24,109
+4,973
+26% +$9.98K 0.01% 779
2016
Q3 		$51K Buy
19,136
+6,470
+51% +$18.8K 0.01% 791
2016
Q2 		$39K Buy
+12,666
New +$79.4K 0.01% 744

Other funds holding IMGN

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wedbush Securities's IMGN Position: Q2 2019 in Review

Wedbush Securities sold out of Immunogen Inc (IMGN) in Q2 2019, closing a stake of 19,581 shares — an estimated $53K sold.

Wedbush Securities first reported a position in IMGN in Q2 2016 and held it in 4 quarters. The position peaked at $53K in Q1 2019. 192 funds tracked by Wall St. Rank hold IMGN as of Q2 2019.

  • Wedbush Securities reported no remaining Immunogen Inc position as of Q2 2019 after selling out during the quarter.
  • Wedbush Securities sold 19,581 Immunogen Inc shares in Q2 2019, an estimated $53K.
  • Wedbush Securities first reported a position in Immunogen Inc in Q2 2016 and held it in 4 quarters.
  • Wedbush Securities's Immunogen Inc position peaked at $53K in Q1 2019.
  • 192 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2019.

Based on Wedbush Securities's 13F filing for Q2 2019, filed 1 Aug 2019.